These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 400732)

  • 1. Degradation and secretion of insulin in hepatic cirrhosis.
    Iwasaki Y; Ohkubo A; Kajinuma H; Akanuma Y; Kosaka K
    J Clin Endocrinol Metab; 1978 Oct; 47(4):774-9. PubMed ID: 400732
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Pancreatic polypeptide response to oral glucose load in patients with liver cirrhosis--interrelationship between PP and other pancreatic endocrine hormones].
    Kawakami K
    Nihon Naibunpi Gakkai Zasshi; 1988 Mar; 64(3):155-70. PubMed ID: 3294051
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Plasma levels of insulin, C-peptide and glucagon in liver cirrhosis.
    Gragnoli G; Signorini AM; Tanganelli I
    J Endocrinol Invest; 1981; 4(1):1-5. PubMed ID: 7016966
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Behavior of plasma insulin, C-peptide and glucagon in normal subjects and in patients with liver cirrhosis].
    Gragnoli G; Tanganelli I; Signorini AM
    Boll Soc Ital Biol Sper; 1980 Jan; 56(1):69-75. PubMed ID: 7002168
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Studies of glucose intolerance in cirrhosis of the liver.
    Shankar TP; Solomon SS; Duckworth WC; Himmelstein S; Gray S; Jerkins T; Bobal MA; Iyer RS
    J Lab Clin Med; 1983 Oct; 102(4):459-69. PubMed ID: 6352838
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential effects of body weight, hyperinsulinemia and oral glucose load on serum C-peptide/insulin molar ratio.
    Okada N; Kobayashi M; Ohtsuka H; Shigematsu S; Nagasawa Y; Komatsu M; Aizawa T; Yamada T
    Horm Metab Res; 1992 Sep; 24(9):429-33. PubMed ID: 1427614
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Analysis of insulin secretion based on changes in plasma insulin and C-peptide in man.
    Sakai T; Ohneda A; Nihei J; Kobayashi T
    Tohoku J Exp Med; 1982 Dec; 138(4):427-40. PubMed ID: 6761899
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Responses of plasma cyclic AMP, serum immunoreactive insulin, C-peptide immunoreactivity and blood sugar levels to glucagon in patients with liver diseases.
    Shimamura J; Taketa K; Ide T; Nakata K; Nagashima H
    Acta Med Okayama; 1985 Oct; 39(5):385-96. PubMed ID: 3000142
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Insulin and C-peptide in chronic liver diseases during oral glucose tolerance testing].
    Oehler G; Knecht M; Bleyl H; Matthes KJ
    Dtsch Med Wochenschr; 1984 Feb; 109(7):253-7. PubMed ID: 6365504
    [TBL] [Abstract][Full Text] [Related]  

  • 10. C-peptide response to glucagon in type 2 diabetes mellitus: a comparison with oral glucose tolerance test.
    Iwasaki Y; Kondo K; Hasegawa H; Oiso Y
    Diabetes Res; 1994; 25(3):129-37. PubMed ID: 7671552
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 3,5,3'-Triiodothyronine regulates insulin level in the circulation following glucose ingestion in humans.
    Koh H; Fujii S; Nishioheda Y; Tsushima M; Nambu S
    Arzneimittelforschung; 1986 Feb; 36(2):262-5. PubMed ID: 3516161
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Glucose, immunoreactive insulin and C-peptide immunoreactivity in patients with acute viral hepatitis.
    Scremin S; Caprioglio L; D'Aquino M; Virgili F; Fabbro A; Okolicsanyi L
    Horm Metab Res; 1983 Jul; 15(7):313-6. PubMed ID: 6350137
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Insulin and C-peptide secretion in non-obese patients with polycystic ovarian disease.
    Mahabeer S; Jialal I; Norman RJ; Naidoo C; Reddi K; Joubert SM
    Horm Metab Res; 1989 Sep; 21(9):502-6. PubMed ID: 2684835
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oral glucose in cirrhotics. Effects on plasma aminoacid patterns and the role of insulin and glucagon.
    Marchesini G; Forlani G; Angiolini A; Zoli M; Scolari MP; Bianchi FB; Pisi E
    Diabete Metab; 1979 Jun; 5(2):135-9. PubMed ID: 478083
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Plasma insulin and C-peptide levels in cirrhotic and uremic patients.
    Kawai K; Hayakawa H; Yoshida K; Shimizu M; Noto Y
    Diabete Metab; 1977 Mar; 3(1):7-10. PubMed ID: 323089
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of collateral vessel occlusion on oral glucose tolerance test in liver cirrhosis.
    Tanabe N; Ishii M; Sato Y; Akahane T; Kobayashi N; Gama H; Iwasaki T; Toyota T
    Dig Dis Sci; 2000 Mar; 45(3):581-6. PubMed ID: 10749336
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Elevated growth hormone levels and insulin resistance in patients with cirrhosis of the liver.
    Shankar TP; Fredi JL; Himmelstein S; Solomon SS; Duckworth WC
    Am J Med Sci; 1986 Apr; 291(4):248-54. PubMed ID: 3518447
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Insulin secretion in alcoholic hepatopathy: analysis by measurement of C-peptide (author's transl)].
    Schlienger JL; Blickle F; Demangeat C; Hasselmann M; Imler M
    Nouv Presse Med; 1978 Dec; 7(44):4011-5. PubMed ID: 733568
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pancreatic glucoregulatory hormones in cirrhosis of the liver: portal vein concentrations during intravenous glucose tolerance test and in response to a meal.
    Holst JJ; Burcharth F; Kühl C
    Diabete Metab; 1980 Jun; 6(2):117-27. PubMed ID: 6997101
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Insulin, C-peptide and glucagon levels during OGTT in hepatic cirrhosis and in patients with prehepatic block.
    Gerö L; Korányi L; Szalay F; Büki B; Tamás G
    Acta Diabetol Lat; 1982; 19(1):55-64. PubMed ID: 7041501
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.